hematopoietic system
• after cre induction using pIpC
• hematological abnormalities in all mice after 16 months
|
• after cre induction by pIpC
• in 11 months
|
• splenomegaly
• myeloid infiltration
|
• defective erythroid development
|
• increased number of mature cells
|
• low white blood cell count
• dysplastic peripheral myeloid cells
|
neoplasm
• after cre induction by pIpC
• in 11 months
|
• after cre induction by pIpC
• 13% succumb to myeloid leukemia by 11 months
• 70% die within two years
|
immune system
• after cre induction by pIpC
• in 11 months
|
• splenomegaly
• myeloid infiltration
|
• increased number of mature cells
|
• low white blood cell count
• dysplastic peripheral myeloid cells
|
endocrine/exocrine glands
• after cre induction by pIpC
• in 11 months
|
growth/size/body
• splenomegaly
• myeloid infiltration
|